Sleep Disorders, Circadian Rhythm: Clinical Trials

10 trials for Sleep Disorders, Circadian Rhythm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 recruiting, 1 unknown. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 6, Recruiting 3, Unknown 1

Follow Sleep Disorders, Circadian Rhythm: new trials by email Literature Review of Sleep Disorders, Circadian Rhythm trials Research Report on Sleep Disorders, Circadian Rhythm

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lemborexant in Delayed Sleep Phase Syndrome
Lemborexant, Placebo - Delayed Sleep Phase Syndrome
Phase 4RecruitingUniversity of California, San Francisco152023-03-132026-06-05
Feasibility Study on the Use of Redormin®500 on Day-time Cognition
Valerian-Hop Extract, Placebo - Sleep Disorders, Circadian Rhythm, Cognitive Dysfunction
Phase 4CompletedMax Zeller Soehne AG402023-03-012026-06-11
The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Interventional)
Blue light exposure + Melatonin treatment, Melatonin treatment, Blue light exposure - Ischemic Stroke, Acute, Sleep Disorders, Circadian Rhythm
Phase 4RecruitingFederal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health802022-03-012025-08-08
Lemborexant in Delayed Sleep Phase Syndrome
Lemborexant, Placebo - Delayed Sleep Phase Syndrome
Phase 4RecruitingStanford University862022-02-012026-10-26
Are Patients Suffering From DSPS Show Compromising in Everyday Functions and Abilities Before Handling the Disorder?
Melatonin and light therapy - Delayed Sleep Phase Syndrome
Phase 4UnknownLilach Kemer202016-11-012016-11-11
Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers
Suvorexant, Placebo - Sleep Disorder, Shift-Work
Phase 4CompletedVA Palo Alto Health Care System192016-02-012020-07-01
Assessments in Stress and Quality of Sleep/Life in Night-shift Nurses and Doctors
massage - Shift-Work Sleep Disorder
Phase 4CompletedTaichung Veterans General Hospital772014-06-012016-07-12
Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)
tasimelteon 20 mg capsule, tasimelteon 2 mg I.V. - Non-24-Hour-Sleep-Wake Disorder
Phase 4CompletedVanda Pharmaceuticals142014-05-012016-08-22
Randomized Controlled Trial on the Treatment Effects of Melatonin and Light Therapy on Delayed Sleep Phase Syndrome
Melatonin, Bright light, Placebo red light - Delayed Sleep Phase Syndrome
Phase 4CompletedUniversity of Bergen402008-10-012016-03-14
Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers
Ramelteon, Placebo - Circadian Dysregulation
Phase 4CompletedTakeda1102007-02-012012-02-28

Narrower conditions

Chronobiology Disorders (1)  ·  Cognitive Dysfunction (1)  ·  Ischemic Stroke (1)  ·  Jet Lag Syndrome (1)  ·  Syndrome (1)

Broader conditions

Dyssomnias (10)  ·  Mental Disorders (10)  ·  Nervous System Diseases (10)  ·  Sleep Wake Disorders (10)  ·  Chronobiology Disorders (9)  ·  Occupational Diseases (9)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Cognition Disorders (1)  ·  Disease (1)  ·  Neurocognitive Disorders (1)  ·  Pathologic Processes (1)

Interventions

Melatonin (2)  ·  lemborexant (2)  ·  Hova (1)  ·  Massage (1)  ·  Phototherapy (1)  ·  ramelteon (1)  ·  suvorexant (1)  ·  tasimelteon (1)

Sponsors

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health (1)  ·  Lilach Kemer (1)  ·  Max Zeller Soehne AG (1)  ·  Stanford University (1)  ·  Taichung Veterans General Hospital (1)  ·  Takeda (1)  ·  University of Bergen (1)  ·  University of California, San Francisco (1)  ·  VA Palo Alto Health Care System (1)  ·  Vanda Pharmaceuticals (1)

Countries

United States (4)  ·  Norway (1)  ·  Russia (1)  ·  Switzerland (1)  ·  Taiwan (1)

Top investigators

Andrew D Krystal, MD, MS (2)  ·  Christiane Gerhards (1)  ·  Emmanuel Mignot, MD, PhD (1)  ·  Lyudmila Korostovtseva (1)  ·  Wayne HH Sheu, MD, PhD (1)

Results publications

PMID 20483660, PMID 24132057, PMID 24144243, PMID 32484552, PMID 40462685